A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing

Aims: To develop and validate a novel Zero-order Absorbance UV-Spectrophotometric method for the quantification of Vardenafil Hydrochloride Trihydrate in commercial tablets and its application for dissolution testing. Background: Erectile Dysfunction (ED) is a significant disorder affecting men's sexual health, with Vardenafil being a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). Vardenafil is commonly used as an oral therapy for treating ED. Accurate and reliable methods for its quantification in pharmaceutical formulations and during dissolution tests are essential for quality control. Objective: To establish and validate a simple, accurate, precise, economical, and sensitive method for determining the concentration of Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests using UV-Spectrophotometry. Method: A Zero-order Absorbance UV-Spectrophotometric approach was employed, utilizing 0.1N HCl as the solvent. The method was optimized to determine Vardenafil hydrochloride trihydrate within a linear range of 2-12 µg/mL, with a coefficient of correlation value greater than 0.99. The method was validated for accuracy, precision, sensitivity, and ruggedness according to ICH guidelines. Additionally, the method was applied for the quantification of Vardenafil hydrochloride trihydrate in dissolution tests. Result: The method successfully determined Vardenafil hydrochloride trihydrate concentration in commercial tablets, showing a % recovery between 99.85% and 100.07%. The % amount of drug estimated was in good agreement with the label claims. The method also allowed direct measurement of samples from the dissolution vessel without pH correction. Conclusion: The developed UV-Spectrophotometric method is a reliable, accurate, and cost-effective approach for quantifying Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests. The method's validation as per ICH guidelines ensures its suitability for routine quality control. Other: This analytical approach provides the simple and economical technique for the analysis of Vardenafil hydrochloride in pharmaceutical formulation.

Authors

Publication Details

Journal
Revista Electronica de Veterinaria
Published
2024-09-23
DOI
https://doi.org/10.69980/redvet.v25i1.999
Primary Topic
Pharmacological Effects and Assays
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing

Bhushan J. Mali
Revista Electronica de Veterinaria
Pharmacological Effects and Assays
article

A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing

Bhushan J. Mali
article en

Abstract

Aims: To develop and validate a novel Zero-order Absorbance UV-Spectrophotometric method for the quantification of Vardenafil Hydrochloride Trihydrate in commercial tablets and its application for dissolution testing. Background: Erectile Dysfunction (ED) is a significant disorder affecting men's sexual health, with Vardenafil being a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). Vardenafil is commonly used as an oral therapy for treating ED. Accurate and reliable methods for its quantification in pharmaceutical formulations and during dissolution tests are essential for quality control. Objective: To establish and validate a simple, accurate, precise, economical, and sensitive method for determining the concentration of Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests using UV-Spectrophotometry. Method: A Zero-order Absorbance UV-Spectrophotometric approach was employed, utilizing 0.1N HCl as the solvent. The method was optimized to determine Vardenafil hydrochloride trihydrate within a linear range of 2-12 µg/mL, with a coefficient of correlation value greater than 0.99. The method was validated for accuracy, precision, sensitivity, and ruggedness according to ICH guidelines. Additionally, the method was applied for the quantification of Vardenafil hydrochloride trihydrate in dissolution tests. Result: The method successfully determined Vardenafil hydrochloride trihydrate concentration in commercial tablets, showing a % recovery between 99.85% and 100.07%. The % amount of drug estimated was in good agreement with the label claims. The method also allowed direct measurement of samples from the dissolution vessel without pH correction. Conclusion: The developed UV-Spectrophotometric method is a reliable, accurate, and cost-effective approach for quantifying Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests. The method's validation as per ICH guidelines ensures its suitability for routine quality control. Other: This analytical approach provides the simple and economical technique for the analysis of Vardenafil hydrochloride in pharmaceutical formulation.

Revista Electronica de Veterinaria
Clean water and sanitation
Openalex Percentile: Top 82%
Pharmacological Effects and Assays
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing — Bhushan J. Mali · Revista Electronica de Veterinaria (2024) | TGRS Research Map | TGRS